Early prediction of sepsis in critically ill trauma patients using machine learning: a MIMIC-IV-based cohort study. Download PDF Abstract This study aimed to develop and validate machine learning (ML) models for the early prediction of incident sepsis in critically ill trauma patients using the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Adult trauma patients with an intensive care unit (ICU) stay of at least 24 h were analysed, excluding those with sepsis or suspected infection during the first 24 h.
Clinical data from the first 24 h of ICU admission were used at hour 24 to predict incident Sepsis-3 during hours 24โ72, and treatment variables and Sequential Organ Failure Assessment (SOFA) scores were excluded to avoid target leakage. Consensus feature selection performed within each training fold retained 19 predictors. Nine ML configurations across seven algorithm families were trained without synthetic oversampling and assessed on a held-out internal evaluation set with 1,000 bootstrap 95% confidence intervals (CIs) and SHapley Additive exPlanations (SHAP).
Among 4,043 trauma ICU patients, 450 (11.13%) developed incident sepsis. Discrimination was moderate and similar across models, with the highest area under the receiver operating characteristic curve (AUROC) obtained by polynomial support vector machine (SVM) (0.734, 95% CI 0.680 to 0.788) and linear SVM (0.733, 95% CI 0.678 to 0.785), both superior to SOFA (0.655) and Simplified Acute Physiology Score II (0.668) (DeLong P < 0.01). Sensitivity ranged from 0.589 to 0.689 and specificity from 0.650 to 0.707, gradient boosting showed the best calibration (slope 0.946, intercept -0.073, Brier score 0.092), and decision curve analysis showed positive net benefit at threshold probabilities of 2% to 35%.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with qualified healthcare professionals for medical decisions and treatment options.
Discover more from ChuckysCarnage
Subscribe to get the latest posts sent to your email.

